Author:
Fiore Josè Ramòn,Centra Michele,De Carlo Armando,Granato Tommaso,Rosa Annamaria,Sarno Michelina,De Feo Lucia,Di Stefano Mariantonietta,D’Errico Maria L.,Caputo Sergio Lo,De Nittis Rosella,Arena Fabio,Corso Gaetano,Margaglione Maurizio,Santantonio Teresa Antonia
Abstract
ABSTRACTHere we present results from a survey on anti-SARS-CoV-2 seroprevalence in healthy blood donors from a low incidence COVID-19 area (Apulia region, South Eastern Italy).Among 904 subjects tested, only in 9 cases (0.99%) antibodies against SARS-CoV-2 were demonstrated. All the 9 seropositive patients were negative for the research of viral RNA by RT-PCR in nasopharyngeal swab.These data, along with those recently reported from other countries, clearly show that we are very far from herd immunity and that the containment measures are at the moment the only realistic instrument we have to slow the spread of the pandemic.
Publisher
Cold Spring Harbor Laboratory
Reference16 articles.
1. Understanding Herd Immunity
2. Herd Immunity: Understanding COVID-19;Immunity,2020
3. Britton T. , Trapman P. , Ball F.G. The disease-induced herd immunity level for Covid-19 is substantially lower than the classical herd immunity level. medRxiv 2020.05.06.20093336; doi: https://doi.org/10.1101/2020.05.06.20093336
4. Gabriela M. , Gomes M. , Corder R. M. , King, J. G. , Langwig K. E. , Souto-Maior, C. et al., Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold. medRxiv 2020.04.27.20081893. https://doi.org/10.1101/2020.04.27.20081893
5. http://www.salute.gov.it/portale/nuovocoronavirus/dettaglioNotizieNuovoCoronavirus.jsp?lingua=italiano&menu=notizie&p=dalministero&id=4870